## Note
nid: 1541613861907
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step2_v11::!FLAG_THESE_CARDS::Potential_duplicates, #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::5psych, #AK_Step2_v11::#AMBOSS::PSYCH, #AK_Step2_v11::#NBME, #AK_Step2_v11::#OME::12_Psychiatry::07_Psychosis, #AK_Step2_v11::#OME::12_Psychiatry::15_Pharm_2, #AK_Step2_v11::#OME_banner::Clinical::12_Psychiatry, #AK_Step2_v11::#Resources_by_rotation::Psych::emma, #AK_Step2_v11::#Subjects::Psychiatry::07_Psychotic_Disorders::Schizophrenia, #AK_Step2_v11::#Subjects::Psychiatry::07_Psychotic_Disorders::Schizophrenia::Pathophysiology, #AK_Step2_v11::Original_decks::Dorian::psych::emma
markdown: false

### Text
What <u>dopaminergic pathway abnormalities</u> are theorized to be
responsible for the <u>positive</u> and <u>negative</u> symptoms of
<b>schizophrenia</b>?
<div>
  Positive symptoms: {{c1::excessive <font color=
  "#FC0280">mesolimbic</font> dopaminergic activity}}
</div>
<div>
  Negative symptoms: {{c1::inadequate <font color=
  "#FC0280">prefrontal cortical</font> or <font color=
  "#FC0280">mesocortical tract</font> dopaminergic activity}}
</div>

### Extra
<img src="paste-1208071221149697.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/psychiatry?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_4.png"></a>
</div>

### Additional Resources


### One by one

